12:00 AM
 | 
Feb 21, 2011
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Crucell sales and marketing update

The World Health Organization (WHO) said it would now accept new shipments of Crucell's Quinvaxem vaccine from the company's Shingal, South Korea, facility after the Korea Food and Drug Administration conducted a quality investigation. WHO said...

Read the full 177 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >